Cited by 750Parkinson's Disease Mechanisms and TreatmentsNuclear Receptors and SignalingUbiquitin and proteasome pathways

The DOI matches its Crossref record; 46 of the 47 references it cites were found in a registry or an index.

Parkin ubiquitinates the α-synuclein–interacting protein, synphilin-1: implications for Lewy-body formation in Parkinson disease

Chung, Kenny K.K., Zhang, Yi, Lim, Kah Leong, Tanaka, Yuji, Huang, Hui, Gao, Jun, Ross, Christopher A., Dawson, Valina L., Dawson, Ted M.·2001·Nature Medicine

DOI 10.1038/nm1001-1144

Open this paper in CoChat — free account

Abstract

Parkinson disease is a common neurodegenerative disorder characterized by the loss of dopaminergic neurons and the presence of intracytoplasmic-ubiquitinated inclusions (Lewy bodies). Mutations in alpha-synuclein (A53T, A30P) and parkin cause familial Parkinson disease. Both these proteins are found in Lewy bodies. The absence of Lewy bodies in patients with parkin mutations suggests that parkin might be required for the formation of Lewy bodies. Here we show that parkin interacts with and ubiquitinates the alpha-synuclein-interacting protein, synphilin-1. Co-expression of alpha-synuclein, synphilin-1 and parkin result in the formation of Lewy-body-like ubiquitin-positive cytosolic inclusions. We further show that familial-linked mutations in parkin disrupt the ubiquitination of synphilin-1 and the formation of the ubiquitin-positive inclusions. These results provide a molecular basis for the ubiquitination of Lewy-body-associated proteins and link parkin and alpha-synuclein in a common pathogenic mechanism through their interaction with synphilin-1.

Integrity signals

Registry

Crossref · 10.1038/nm1001-1144

Cites

46 of 46 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Molecular Cloning: A Laboratory Manual
Sambrook, J., Fritsch, E., & Maniatis, T. (1989) · UCLA - Biblioteca de Ciencias de la Salud · Cited by 133,589
Molecular cloning: A laboratory manual
Deininger, P. L. (1990) · Analytical Biochemistry · doi:10.1016/0003-2697(90)90595-z · Cited by 84,684
α-Synuclein in Lewy bodies
Spillantini, M. G., Schmidt, M. L., Lee, V. M.-Y., Trojanowski, J. Q., Jakes, R., & Goedert, M. (1997) · Nature · doi:10.1038/42166 · Cited by 8,382
Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease
Polymeropoulos, M. H., Lavedan, C., Leroy, E., Ide, S. E., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R., et al. (1997) · Science · doi:10.1126/science.276.5321.2045 · Cited by 8,240
Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism
Kitada, T., Asakawa, S., Hattori, N., Matsumine, H., Yamamura, Y., Minoshima, S., Yokochi, M., Mizuno, Y., & Shimizu, N. (1998) · Nature · doi:10.1038/33416 · Cited by 5,227
AlaSOPro mutation in the gene encoding α-synuclein in Parkinson's disease
Krüger, R., Kuhn, W., Müller, T., Woitalla, D., Graeber, M., Kösel, S., Przuntek, H., Epplen, J. T., Schols, L., & Riess, O. (1998) · Nature Genetics · doi:10.1038/ng0298-106 · Cited by 3,836
α-synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with lewy bodies
Spillantini, M. G., Crowther, R. A., Jakes, R., Hasegawa, M., & Goedert, M. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.11.6469 · Cited by 2,868
A Drosophila model of Parkinson's disease
Feany, M. Β., & Bender, W. W. (2000) · Nature · doi:10.1038/35006074 · Cited by 2,156
Parkinson's Disease
Lang, A. E., & Lozano, A. M. (1998) · New England Journal of Medicine · doi:10.1056/nejm199810083391506 · Cited by 2,072
Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase
Shimura, H., Hattori, N., Kubo, S.-I., Mizuno, Y., Asakawa, S., Minoshima, S., Shimizu, N., Iwai, K., Chiba, T., Tanaka, K., et al. (2000) · Nature Genetics · doi:10.1038/77060 · Cited by 2,024

Flagged first, then by citations

Show all 47 references

1 of the 47 references couldn’t be matched to a known paper.

Research works printed but not linked: 1

Chung, K.K.K., Dawson, V.L. & Dawson, T.M. The role of the ubiquitin proteasomal pathway in Parkinson's disease and other neurogenerative diseases. Trends Neurosci. (in the press).

Sorted by citations

Items 301–400 of 744

Behavioral phenotypes and pharmacology in genetic mouse models of Parkinsonism
Fleming, S. M., & Chesselet, M. (2006) · Behavioural Pharmacology · doi:10.1097/00008877-200609000-00004 · Cited by 60
Molecular mechanisms of nitrosative stress-mediated protein misfolding in neurodegenerative diseases
Nakamura, T., & Lipton, S. A. (2007) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-007-6525-0 · Cited by 60
Silica-coated magnetic nanoparticles impair proteasome activity and increase the formation of cytoplasmic inclusion bodies in vitro
Phukan, G., Shin, T. H., Shim, J. S., Paik, M., Lee, J.-K., Choi, S., Kim, Y. M., Kang, S. H., Kim, H. S., KANG, Y. Y., et al. (2016) · Scientific Reports · doi:10.1038/srep29095 · Cited by 59
Synaptic dysfunction in genetic models of Parkinson's disease: A role for autophagy?
Plowey, E. D., & Chu, C. T. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2010.10.011 · Cited by 62
Role for the Ubiquitin-Proteasome System in Parkinson's Disease and Other Neurodegenerative Brain Amyloidoses
Moore, D. J., Dawson, V. L., & Dawson, T. M. (2003) · NeuroMolecular Medicine · doi:10.1385/nmm:4:1-2:95 · Cited by 59
Self-citation
Structural Mechanisms of Mitochondrial Quality Control Mediated by PINK1 and Parkin
Trempe, J., & Gehring, K. (2023) · Journal of Molecular Biology · doi:10.1016/j.jmb.2023.168090 · Cited by 63
Degrons: defining the rules of protein degradation
Zhang, Z., Mena, E. L., Timms, R. T., Koren, I., & Elledge, S. J. (2025) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-025-00870-z · Cited by 67
RuvbL1 and RuvbL2 enhance aggresome formation and disaggregate amyloid fibrils
Zaarur, N., Xu, X., Lestienne, P. P., Meriin, A. B., McComb, M. E., Costello, C. E., Newnam, G. P., Ganti, R., Romanova, N. V., Shanmugasundaram, M., et al. (2015) · The EMBO Journal · doi:10.15252/embj.201591245 · Cited by 59
Parkin is an E3 ubiquitin-ligase for normal and mutant ataxin-2 and prevents ataxin-2-induced cell death
Huynh, D. P., Nguyen, D., Pulst‐Korenberg, J., Brice, A., & Pulst, S.-M. (2006) · Experimental Neurology · doi:10.1016/j.expneurol.2006.09.009 · Cited by 58
RING Finger Ubiquitin-Protein Isopeptide Ligase Nrdp1/FLRF Regulates Parkin Stability and Activity
Zhong, L., Tan, Y., Zhou, A., Yu, Q., & Zhou, J. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m408955200 · Cited by 57
Direct Binding with Histone Deacetylase 6 Mediates the Reversible Recruitment of Parkin to the Centrosome
Jiang, Q., Ren, Y., & Feng, J. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.2860-08.2008 · Cited by 59
How do Parkin mutations result in neurodegeneration?
Imai, Y., & Takahashi, R. (2004) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2004.04.002 · Cited by 57
Neddylation positively regulates the ubiquitin E3 ligase activity of parkin
Um, J. W., Han, K. A., Im, E., Oh, Y., Lee, K., & Chung, K. C. (2012) · Journal of Neuroscience Research · doi:10.1002/jnr.22828 · Cited by 56
Self-citation
Use of viral vectors to create animal models for Parkinson's disease
Löw, K., & Aebischer, P. (2011) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.12.038 · Cited by 60
Aggregopathy in Neurodegenerative Diseases: Mechanisms and Therapeutic Implication
Dohm, C. P., Kermer, P., & Bähr, M. (2008) · Neurodegenerative Diseases · doi:10.1159/000119459 · Cited by 56
Transgenic rodent models of Parkinson’s disease
Harvey, B. K., Wang, Y., & Hoffer, B. J. (2009) · Acta neurochirurgica. Supplementum · doi:10.1007/978-3-211-78205-7_15 · Cited by 55
S-Nitrosylation and uncompetitive/fast off-rate (UFO) drug therapy in neurodegenerative disorders of protein misfolding
Nakamura, T., & Lipton, S. A. (2007) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4402138 · Cited by 54
Dorfin Localizes to the Ubiquitylated Inclusions in Parkinson's Disease, Dementia with Lewy Bodies, Multiple System Atrophy, and Amyotrophic Lateral Sclerosis
Hishikawa, N., Niwa, J.-I., Doyu, M., Ito, T., Ishigaki, S., Hashizume, Y., & Sobue, G. (2003) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63688-7 · Cited by 54
Pesticides and metals induced Parkinson's disease: involvement of free radicals and oxidative stress.
Singh, C., Ahmad, I., & Kumar, A. (2007) · PubMed · Cited by 54
The Role of α-Synuclein Assembly and Metabolism in the Pathogenesis of Lewy Body Disease
Hashimoto, M., Kawahara, K., Bar‐On, P., Rockenstein, E. M., Crews, L. A., & Masliah, E. (2004) · Journal of Molecular Neuroscience · doi:10.1385/jmn:24:3:343 · Cited by 53
Twenty years since the discovery of the parkin gene
Hattori, N., & Mizuno, Y. (2017) · Journal of Neural Transmission · doi:10.1007/s00702-017-1742-7 · Cited by 55
Corneal dystrophies
Soh, Y. Q., Kocaba, V., Weiss, J. S., Jurkunas, U. V., Kinoshita, S., Aldave, A. J., & Mehta, J. S. (2020) · Nature Reviews Disease Primers · doi:10.1038/s41572-020-0178-9 · Cited by 53
Mutant α-synuclein-induced degeneration is reduced by parkin in a fly model of Parkinson's disease
Haywood, A. F. M., & Staveley, B. E. (2006) · Genome · doi:10.1139/g06-011 · Cited by 53
The proteasomal subunit S6 ATPase is a novel synphilin-1 interacting protein—implications for Parkinson's disease.
Marx, F. P., Soehn, A. S., Berg, D., Melle, C., Schiesling, C., Lang, M., Kautzmann, S., Strauss, K. M., Franck, T., Engelender, S., et al. (2007) · The FASEB Journal · doi:10.1096/fj.06-6734com · Cited by 52
Parkin regulates paclitaxel sensitivity in breast cancer via a microtubule‐dependent mechanism
Wang, H., Liu, B., Zhang, C., Peng, G., Liu, M., Li, D., Gu, F., Chen, Q., Dong, J., Fu, L., et al. (2009) · The Journal of Pathology · doi:10.1002/path.2512 · Cited by 52
Disease-modifying drugs and Parkinson's disease
Allain, H., Bentué‐Ferrer, D., & Akwa, Y. (2007) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2007.10.003 · Cited by 52
The synaptic function of parkin
Sassone, J., Serratto, G. M., Valtorta, F., Silani, V., Passafaro, M., & Ciammola, A. (2017) · Brain · doi:10.1093/brain/awx006 · Cited by 52
Neuroprotective effects of boron nitride nanoparticles in the experimental Parkinson’s disease model against MPP+ induced apoptosis
Küçükdoğru, R., Türkez, H., Arslan, M. E., Tozlu, Ö. Ö., Sönmez, E., Mardinoğlu, A., Cacciatore, I., & Stefano, A. D. (2020) · Metabolic Brain Disease · doi:10.1007/s11011-020-00559-6 · Cited by 51
SUMO and Parkinson’s Disease
Eckermann, K. (2013) · NeuroMolecular Medicine · doi:10.1007/s12017-013-8259-5 · Cited by 52
Neural Regeneration
Steward, M., Sridhar, A., & Meyer, J. S. (2012) · Current topics in microbiology and immunology · doi:10.1007/82_2012_302 · Cited by 53
Protein stability and aggregation in Parkinson's disease
Robinson, P. A. (2008) · Biochemical Journal · doi:10.1042/bj20080295 · Cited by 50
Parkin's Substrates and the Pathways Leading to Neuronal Damage
Cookson, M. (2003) · NeuroMolecular Medicine · doi:10.1385/nmm:3:1:1 · Cited by 50
Analysis of alpha-synuclein, dopamine and parkin pathways in neuropathologically confirmed parkinsonian nigra
Moran, L. B., Croisier, E., Duke, D. C., Kalaitzakis, M. E., Roncaroli, F., Deprez, M., Dexter, D. T., Pearce, R. K. B., & Graeber, M. B. (2007) · Acta Neuropathologica · doi:10.1007/s00401-006-0181-6 · Cited by 50
- α-Synuclein and Parkinson’s Disease
Gasser, T. (2012) · CRC Press eBooks · doi:10.1201/b12948-15 · Cited by 50
The regulatory role of α-synuclein and parkin in neuronal cell apoptosis; possible implications for the pathogenesis of Parkinson’s disease
Yasuda, T., & Mochizuki, H. (2010) · APOPTOSIS · doi:10.1007/s10495-010-0486-8 · Cited by 51
Parkin-dependent regulation of the MCU complex component MICU1
Matteucci, A., Patrón, M., Reane, D. V., Gastaldello, S., Amoroso, S., Rizzuto, R., Brini, M., Raffaello, A., & Calí, T. (2018) · Scientific Reports · doi:10.1038/s41598-018-32551-7 · Cited by 50
A Sporadic Parkinson Disease Model via Silencing of the Ubiquitin-Proteasome/E3 Ligase Component SKP1A
Fishman-Jacob, T., Reznichenko, L., Youdim, M. B. H., & Mandel, S. A. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.034223 · Cited by 50
Effect of proteasome inhibitor on cultured mesencephalic dopaminergic neurons
Kikuchi, S., Shinpo, K., Tsuji, S., Takeuchi, M., Yamagishi, S.-I., Makita, Z., Niino, M., Yabe, I., & Tashiro, K. (2003) · Brain Research · doi:10.1016/s0006-8993(02)04030-1 · Cited by 49
Altered α‐synuclein, parkin, and synphilin isoform levels in multiple system atrophy brains
Brudek, T., Winge, K., Rasmussen, N. B., Bahl, J. M. C., Tanassi, J. T., Agander, T. K., Hyde, T. M., & Pakkenberg, B. (2015) · Journal of Neurochemistry · doi:10.1111/jnc.13392 · Cited by 48
Chasing genes in Alzheimer?s and Parkinson?s disease
Bertoli‐Avella, A. M., Oostra, B. A., & Heutink, P. (2004) · Human Genetics · doi:10.1007/s00439-004-1097-7 · Cited by 48
The neurological mutant quaking viable is Parkin deficient
Lorenzetti, D., Antalffy, B. A., Vogel, H. S., Noveroske, J. K., Armstrong, D. L., & Justice, M. J. (2004) · Mammalian Genome · doi:10.1007/s00335-003-2333-5 · Cited by 48
α-Synuclein Aggregation: A Link Between Mitochondrial Defects and Parkinson's Disease?
Lee, S. (2003) · Antioxidants and Redox Signaling · doi:10.1089/152308603322110904 · Cited by 48
Wild-type and mutant α-synuclein induce a multi-component gene expression profile consistent with shared pathophysiology in different transgenic mouse models of PD
Miller, R. M., Kiser, G. L., Kaysser-Kranich, T., Casaceli, C., Colla, E., Lee, M. K., Palaniappan, C., & Federoff, H. J. (2007) · Experimental Neurology · doi:10.1016/j.expneurol.2006.12.005 · Cited by 47
Modeling Neurodegenerative Diseases in vivo Review
Halbach, O. V. B. U. (2005) · Neurodegenerative Diseases · doi:10.1159/000092318 · Cited by 47
Heterogeneity of Nigral and Cortical Lewy Bodies Differentiated by Amplified Triple-Labeling for Alpha-Synuclein, Ubiquitin, and Thiazin Red
Sakamoto, M., Uchihara, T., Hayashi, M., Nakamura, A., Kikuchi, E., Mizutani, T., Mizusawa, H., & Hirai, S. (2002) · Experimental Neurology · doi:10.1006/exnr.2002.7961 · Cited by 47
A role for viral infections in Parkinson’s etiology?
Olsen, L. K., Dowd, E., & McKernan, D. P. (2018) · Neuronal Signaling · doi:10.1042/ns20170166 · Cited by 48
Genetic Mouse Models of Neurodegenerative Diseases
Trancikova, A. K., Ramonet, D., & Moore, D. J. (2011) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-384878-9.00012-1 · Cited by 47
Thioredoxin Suppresses Parkin-associated Endothelin Receptor-like Receptor-induced Neurotoxicity and Extends Longevity in Drosophila
Umeda‐Kameyama, Y., Tsuda, M., Ohkura, C., Matsuo, T., Namba, Y., Ohuchi, Y., & Aigaki, T. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m700937200 · Cited by 46
Synphilin-1A: An aggregation-prone isoform of synphilin-1 that causes neuronal death and is present in aggregates from α-synucleinopathy patients
Eyal, A., Szargel, R., Avraham, E., Liani, E., Haskin, J., Rott, R., & Engelender, S. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0509707103 · Cited by 47
Parkin differently regulates presenilin-1 and presenilin-2 functions by direct control of their promoter transcription
Duplan, E., Sévalle, J., Viotti, J., Goiran, T., Bauer, C., Renbaum, P., Levy‐Lahad, E., Gautier, C., Corti, O., Leroudier, N., et al. (2013) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjt003 · Cited by 45
Assembly of Lysine 63-linked Ubiquitin Conjugates by Phosphorylated α-Synuclein Implies Lewy Body Biogenesis
Liu, C., Fei, E., Jia, N., Wang, H., Tao, R.-S., Iwata, A., Nukina, N., Zhou, J., & Wang, G. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m700422200 · Cited by 45
Parkinsons Disease: Genetics and Beyond
Inamdar, N., Arulmozhi, D. K., Tandon, A., & Bodhankar, S. L. (2007) · Current Neuropharmacology · doi:10.2174/157015907780866893 · Cited by 46
Accumulation of the parkin substrate, FAF1, plays a key role in the dopaminergic neurodegeneration
Sul, J.-W., Park, M., Shin, J., Kim, Y., Yoo, S., Kong, Y., Kwon, K., Lee, Y., & Kim, E. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt006 · Cited by 44
Balance is the challenge – The impact of mitochondrial dynamics in Parkinson’s disease
Burbulla, L. F., Krebiehl, G., & Krüger, R. (2010) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2010.02354.x · Cited by 46
Synphilin-1 and parkin show overlapping expression patterns in human brain and form aggresomes in response to proteasomal inhibition
Bandopadhyay, R., Kingsbury, A. E., Muqit, M. M. K., Harvey, K., Reid, A. R., Kilford, L., Engelender, S., Schlossmacher, M. G., Wood, N. W., Latchman, D. S., et al. (2005) · Neurobiology of Disease · doi:10.1016/j.nbd.2005.03.021 · Cited by 44
Parkin Disrupts the α-Synuclein/Dopamine Transporter Interaction: Consequences Toward Dopamine-induced Toxicity
Moszczyńska, A., Saleh, J., Zhang, H., Vukusic, B., Lee, F. J. S., & Liu, F. (2007) · Journal of Molecular Neuroscience · doi:10.1007/s12031-007-0037-0 · Cited by 46
Ageing enhances α-synuclein, ubiquitin and endoplasmic reticular stress protein expression in the nigral neurons of Asian Indians
Alladi, P. A., Mahadevan, A., Vijayalakshmi, K., Muthane, U. B., Shankar, S. K., & Raju, T. R. (2010) · Neurochemistry International · doi:10.1016/j.neuint.2010.06.018 · Cited by 44
Neuroprotective Mechanisms of Antiparkinsonian Dopamine D2-Receptor Subfamily Agonists
Kitamura, Y., Taniguchi, T., Shimohama, S., Akaike, A., & Nomura, Y. (2003) · Neurochemical Research · doi:10.1023/a:1023207222944 · Cited by 44
Monitoring the ubiquitin/proteasome system in conformational diseases
Lindsten, K., & Dantuma, N. P. (2003) · Ageing Research Reviews · doi:10.1016/s1568-1637(03)00031-x · Cited by 45
Cellular functions regulated by deubiquitinating enzymes in neurodegenerative diseases
Do, H., & Baek, K. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101367 · Cited by 45
Loss-of-Function Rodent Models for Parkin and PINK1
Oliveras-Salvá, M., Rompuy, A. V., Heeman, B., den Haute, C. V., & Baekelandt, V. (2011) · Journal of Parkinson s Disease · doi:10.3233/jpd-2011-11041 · Cited by 44
Substrate receptors of proteasomes
Jiang, T.-X., Zhao, M., & Qiu, X. (2018) · Biological reviews/Biological reviews of the Cambridge Philosophical Society · doi:10.1111/brv.12419 · Cited by 44
Acrolein-mediated alpha-synuclein pathology involvement in the early post-injury pathogenesis of mild blast-induced Parkinsonian neurodegeneration
Acosta, G., Race, N. S., Herr, S., Fernandez, J., TANG, J. C. Y., Rogers, E. A., & Shi, R. (2019) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2019.06.004 · Cited by 44
Genetic factors involved in the pathogenesis of Parkinson's disease
Lee, F. J. S., & Liu, F. (2008) · Brain Research Reviews · doi:10.1016/j.brainresrev.2008.02.001 · Cited by 43
Alpha‐synuclein‐associated changes in PINK1‐PRKN‐mediated mitophagy are disease context dependent
Hou, X., Chen, T. H., Koga, S., Bredenberg, J. M., Faroqi, A. H., Delenclos, M., Bu, G., Wszołek, Z. K., Carr, J. A., Ross, O. A., et al. (2023) · Brain Pathology · doi:10.1111/bpa.13175 · Cited by 42
The Role of Ubiquitin–Proteasome System and Mitophagy in the Pathogenesis of Parkinson's Disease
Yú, L., Zhong, G., Ren, M., Sun, T., Li, Y., Ye, M., Ma, C., Guo, Y., & Liu, C. (2023) · NeuroMolecular Medicine · doi:10.1007/s12017-023-08755-0 · Cited by 42
Isoform specific regulation of divalent metal (ion) transporter (DMT1) by proteasomal degradation
Garrick, M. D., Zhao, L., Roth, J. A., Jiang, H., Feng, J., Foot, N. J., Dalton, H. E., Kumar, S., & Garrick, L. M. (2012) · BioMetals · doi:10.1007/s10534-012-9522-1 · Cited by 42
The E3 Ubiquitin Ligase Parkin Is Recruited to the 26 S Proteasome via the Proteasomal Ubiquitin Receptor Rpn13
Aguileta, M., Korać-Prlić, J., Durcan, T. M., Trempe, J., Haber, M., Gehring, K., Elsasser, S., Waidmann, O., Fon, E. A., & Husnjak, K. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.614925 · Cited by 43
Regulation of DNA repair by parkin
Kao, S. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.03.048 · Cited by 42
Genetics of Parkinson disease
Pankratz, N., & Foroud, T. (2004) · NeuroRx · doi:10.1602/neurorx.1.2.235 · Cited by 42
Exploring genetic alterations in circulating tumor DNA from cerebrospinal fluid of pediatric medulloblastoma
Sun, Y., Li, M., Ren, S., Liu, Y., Zhang, J., Li, S., Gao, W., Gong, X., Liu, J., Wang, Y., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-85178-6 · Cited by 43
The Cast of Molecular Characters in Parkinson's Disease
LIM, K. L., Dawson, V. L., & Dawson, T. M. (2003) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2003.tb07465.x · Cited by 41
Self-citation
DNA damage induces nuclear translocation of parkin
Kao, S. (2009) · Journal of Biomedical Science · doi:10.1186/1423-0127-16-67 · Cited by 43
Parkinson’s disease-linked Parkin mutations impair glutamatergic signaling in hippocampal neurons
Zhu, M. J., Cortese, G. P., & Waites, C. L. (2018) · BMC Biology · doi:10.1186/s12915-018-0567-7 · Cited by 43
Protein misfolding and dysregulated protein homeostasis in autoinflammatory diseases and beyond
Agyemang, A. F., Harrison, S. R., Siegel, R. M., & McDermott, M. (2015) · Seminars in Immunopathology · doi:10.1007/s00281-015-0496-2 · Cited by 41
Protein aggregation in Parkinson’s disease
Gundersen, V. (2010) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2010.01382.x · Cited by 40
Parkin Deficiency Delays Motor Decline and Disease Manifestation in a Mouse Model of Synucleinopathy
Fournier, M., Vitte, J., Garrigue, J., Langui, D., Dullin, J.-P., Saurini, F., Hanoun, N., Pérez-Díaz, F., Cornilleau, F., Joubert, C., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006629 · Cited by 42
The Cellular Protein Level of Parkin Is Regulated by Its Ubiquitin-like Domain
Finney, N., Walther, F., Mantel, P., Stauffer, D., Rovelli, G., & Dev, K. K. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.c300051200 · Cited by 40
PLK2 Modulates α-Synuclein Aggregation in Yeast and Mammalian Cells
Basso, E., Antas, P., Marijanovic, Z., Gonçalves, S. A., Tenreiro, S., & Outeiro, T. F. (2013) · Molecular Neurobiology · doi:10.1007/s12035-013-8473-z · Cited by 41
Alternative Splicing Generates Different Parkin Protein Isoforms: Evidences in Human, Rat, and Mouse Brain
Scuderi, S., Cognata, V. L., Drago, F., Cavallaro, S., & D’Agata, V. (2014) · BioMed Research International · doi:10.1155/2014/690796 · Cited by 42
Recessive Parkinson's disease
Kubo, S., Hattori, N., & Mizuno, Y. (2006) · Movement Disorders · doi:10.1002/mds.20841 · Cited by 39
Long-Term Overexpression of Human Wild-Type and T240R Mutant Parkin in Rat Substantia Nigra Induces Progressive Dopaminergic Neurodegeneration
Rompuy, A. V., Lobbestael, E., der Perren, A. V., den Haute, C. V., & Baekelandt, V. (2014) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0000000000000039 · Cited by 38
Caspase-3-derived C-terminal Product of Synphilin-1 Displays Antiapoptotic Function via Modulation of the p53-dependent Cell Death Pathway
Giaime, E., Sunyach, C., Herrant, M., Grosso, S., Auberger, P., McLean, P. J., Checler, F., & da Costa, C. A. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m508619200 · Cited by 38
Transgenic animal models of neurodegeneration based on human genetic studies
Harvey, B. K., Richie, C. T., Hoffer, B. J., & Airavaara, M. (2010) · Journal of Neural Transmission · doi:10.1007/s00702-010-0476-6 · Cited by 38
Synphilin-1 attenuates mutant LRRK2-induced neurodegeneration in Parkinson's disease models
Liu, J., Li, T., Thomas, J. M., Pei, Z., Jiang, H., Engelender, S., Ross, C. A., & Smith, W. W. (2016) · Human Molecular Genetics · doi:10.1093/hmg/ddv504 · Cited by 39
Self-citation
Synphilin‐1 degradation by the ubiquitin‐proteasome pathway and effects on cell survival
Lee, G., Junn, E., Tanaka, M., Kim, Y. M., Lee, S. S., & Mouradian, M. M. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.01136.x · Cited by 38
Parkin and synphilin-1 isoform expression changes in Lewy body diseases
Humbert, J., Beyer, K., Carrato, C., Mate, J. L., Ferrer, I., & Ariza, A. (2007) · Neurobiology of Disease · doi:10.1016/j.nbd.2007.03.007 · Cited by 38
Molecular pathogenesis of Parkinson's disease: Identification of mutations in the Parkin gene in Indian patients
Biswas, A., Gupta, A., Naiya, T., Das, G., Neogi, R., Datta, S., Mukherjee, S., Das, S. K., Ray, K., & Ray, J. (2006) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2006.04.005 · Cited by 38
Parkin and mitochondrial signalling
Connelly, E. M., Frankel, K. S., & Shaw, G. S. (2023) · Cellular Signalling · doi:10.1016/j.cellsig.2023.110631 · Cited by 38
Pharmacological Therapy in Parkinson's Disease: Focus on Neuroprotection
Kincses, Z. T., & Vécsei, L. (2010) · CNS Neuroscience & Therapeutics · doi:10.1111/j.1755-5949.2010.00150.x · Cited by 39
Aggregate formation and toxicity by wild‐type and R621C synphilin‐1 in the nigrostriatal system of mice using adenoviral vectors
Krenz, A., Falkenburger, B. H., Gerhardt, E., Drinkut, A., & Schulz, J. B. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05755.x · Cited by 37
Parkin Promotes Degradation of the Mitochondrial Pro-Apoptotic ARTS Protein
Kemeny, S., Dery, D., Loboda, Y., Rovner, M., Lev, T., Zuri, D., Finberg, J. P. M., & Larisch, S. (2012) · PLoS ONE · doi:10.1371/journal.pone.0038837 · Cited by 37
Synucleins and their relationship to Parkinson’s disease
Halbach, O. V. B. U. (2004) · Cell and Tissue Research · doi:10.1007/s00441-004-0921-7 · Cited by 37
Association of translation factor eEF1A with defective ribosomal products generates a signal for aggresome formation.
Meriin, A. B., Zaarur, N., & Sherman, M. Y. (2012) · Journal of Cell Science · doi:10.1242/jcs.098954 · Cited by 37
Linking F-box protein 7 and parkin to neuronal degeneration in Parkinson’s disease (PD)
Zhou, Z., Sathiyamoorthy, S., Angeles, D. C., & Tan, E. K. (2016) · Molecular Brain · doi:10.1186/s13041-016-0218-2 · Cited by 36
Parkinson Disease: Translating Insights from Molecular Mechanisms to Neuroprotection
Pirooznia, S. K., Rosenthal, L. S., Dawson, V. L., & Dawson, T. M. (2021) · Pharmacological Reviews · doi:10.1124/pharmrev.120.000189 · Cited by 36
Self-citation
Synphilin-1 inhibits alpha-synuclein degradation by the proteasome
Alvarez‐Castelao, B., & Castaño, J. G. (2010) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-010-0592-3 · Cited by 37
Inhibition of Protein Tyrosine/Mitogen-Activated Protein Kinase Phosphatase Activity Is Associated with D2 Dopamine Receptor Supersensitivity in a Rat Model of Parkinson's Disease
Zhen, X., Torres, C. A., Cai, G., & Friedman, E. (2002) · Molecular Pharmacology · doi:10.1124/mol.62.6.1356 · Cited by 36
Synphilin in normal human brains and in synucleinopathies: studies with new antibodies
Murray, I. V. J., Medford, M. A., Guan, H.-P., Rueter, S. M., Trojanowski, J. Q., & Lee, V. M. ‐. (2003) · Acta Neuropathologica · doi:10.1007/s00401-002-0629-2 · Cited by 36
Clinical and Dopamine Transporter Imaging Trajectories in a Cohort of Parkinson's Disease Patients with GBA Mutations
Caminiti, S. P., Carli, G., Avenali, M., Blandini, F., & Perani, D. (2021) · Movement Disorders · doi:10.1002/mds.28818 · Cited by 35

Authors: Chung, K. K. K., Zhang, Y., Lim, K. L., Tanaka, Y., Huang, H., Gao, J., Ross, C. A., Dawson, V. L., & Dawson, T. M.
Affiliations: Johns Hopkins University (US)
Corresponding author: Dawson, Ted M.
ORCID: Chung, Kenny K.K.
Zhang, Yi
Tanaka, Yuji
Huang, Hui
Dawson, Valina L.
Dawson, Ted M.
Venue: Nature Medicine
Publisher: Springer Science and Business Media LLC
Published: 2001-10
Volume: 7
Issue: 10
Pages: 1144-1150
ISSN: 1078-8956 (ISSN-L)
1546-170X
DOI: 10.1038/nm1001-1144
OpenAlex: W1529474377
Cited by: 750
References: 47
Citations by year: 2026: 10 · 2025: 11 · 2024: 15 · 2023: 22 · 2022: 11 · 2021: 23 · 2020: 18 · 2019: 12 · 2018: 14 · 2017: 21 · 2016: 22 · 2015: 20 · 2014: 17 · 2013: 17 · 2012: 27
FWCI: 42.95
Type: journal article
Language: en
Open access: closed
Licence: www.springer.com/tdm (tdm)
Locations: Nature Medicine (publishedVersion)
PubMed (publishedVersion)
Rare & Special e-Zone (The Hong Kong University of Science and Technology) (submittedVersion)
National University of Singapore (submittedVersion)
Funders: National Institute of Neurological Disorders and Stroke (NS 38377, P50NS038377)
Topics: Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Receptors and Signaling
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
Keywords: Parkin, synphilin-1, alpha-synuclein, ubiquitination, Lewy bodies, Parkinson's disease, familial Parkinson's disease, protein-protein interaction, ubiquitin-positive inclusions, parkin mutations, alpha-synuclein mutations
MeSH terms: Animals, Carrier Proteins, Cell Line, Glycosylation, Humans, Ligases, Nerve Tissue Proteins, Parkinson Disease, Ubiquitins, Mutagenesis, Lewy Bodies, Ubiquitin-Protein Ligases, Rats, Synucleins, alpha-Synuclein

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Parkin ubiquitinates the α-synuclein–interacting protein, synphilin-1: implications for Lewy-body formation in Parkinson disease

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks